Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Cancer Extensive Stage × Immunotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 36 Melanoma 14 Neoplasm Metastasis 13 Lung Neoplasms 12 Esophageal Neoplasms 10 Carcinoma, Hepatocellular 10 Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Colorectal Neoplasms 7 Breast Neoplasms 7 Esophageal Squamous Cell Carcinoma 6 Stomach Neoplasms 5 Rectal Neoplasms 5 Head and Neck Neoplasms 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Uterine Cervical Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Brain Neoplasms 3 Sarcoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Neuroblastoma 2 Neoplasm, Residual 2 Locally Advanced Non-small Cell Lung Cancer 2

Interventions

Etoposide 4 Carboplatin 4 atezolizumab 3 Radiotherapy 2 tislelizumab 1 sintilimab 1 pembrolizumab 1 irinotecan sucrosofate 1 durvalumab 1 camrelizumab 1 apatinib 1 anlotinib 1 Platinum 1 Paclitaxel 1 Observation 1 NPI 2358 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Epirubicin 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06610734 2026-02-09

SKY

Sichuan University

Phase 2 Recruiting

Small Cell Lung Cancer Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡